-
Basic and Translational Oral Health Research Related to HIV/AIDS (R21 Clinical Trial Not Allowed)
(PA-18-695)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Basic and Translational Oral Health Research Related to HIV/AIDS (R01 Clinical Trial Not Allowed)
(PA-18-699)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) (Clinical Trials Not Allowed)
(PA-18-700)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp - Clinical Trial Not Allowed)
(PA-18-702)
National Institute of Biomedical Imaging and Bioengineering
National Institute of Diabetes and Digestive and Kidney Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): June 1, 2018, and August 1, 2018, by 5:00 PM local time of applicant organization.
-
SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)
(PA-18-705)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Eye Institute
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
*** Note new SBIR/STTR Standard Due Dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
(PAR-18-696)
National Center for Complementary and Integrative Health
Application Receipt Date(s): New Applications: June 7, 2018; February 7, 2019; and October 7, 2019
Resubmission and Renewal Applications: June 21, 2018; February 21, 2019; and October 21, 2019
, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Natural Product, Multi-Site, Clinical Trial, Data Coordinating Center (Collaborative U24 - Clinical Trial Required)
(PAR-18-697)
National Center for Complementary and Integrative Health
Application Receipt Date(s): New Applications: June 7, 2018; February 7, 2019; and October 7, 2019
Resubmission and Renewal Applications: June 21, 2018, February 21, 2019, and October 21, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional)
(PAR-18-701)
National Institute of Mental Health
Application Receipt Date(s): May 17, 2018, May 17, 2019, June 30, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Not Allowed)
(PAR-18-703)
National Cancer Institute
National Institute of Environmental Health Sciences
Application Receipt Date(s): July 11, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Not Allowed)
(PAR-18-704)
National Cancer Institute
National Institute of Environmental Health Sciences
Application Receipt Date(s): July 11, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01 - Clinical Trial Not Allowed)
(PAR-18-706)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional)
(PAR-18-707)
National Eye Institute
Application Receipt Date(s): April 10, 2018; April 10, 2019; April 10, 2020), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
High Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)
(PAS-18-698)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Autoimmunity Centers of Excellence, Basic Research Program (U19 Clinical Trial Not Allowed)
(RFA-AI-18-002)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 22, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Autoimmunity Centers of Excellence, Clinical Research Program (UM1 Clinical Trial Required)
(RFA-AI-18-003)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 22, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)
(RFA-CA-18-019)
National Cancer Institute
Application Receipt Date(s): June 29, 2018, October 30, 2018), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)
(RFA-CA-18-020)
National Cancer Institute
Application Receipt Date(s): June 29, 2018, October 30, 2018), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Science-Based Quality Measurement and Management Development for Opioid Use Disorder Treatment (R61/R33 Clinical Trial Required)
(RFA-DA-19-005)
National Institute on Drug Abuse
Application Receipt Date(s): November 7, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
National Dental Practice-Based Research Network: Administrative and Resource Center (U19 Clinical Trial Required)
(RFA-DE-19-001)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): July 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Late applications in response to this FOA will not be accepted.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
National Dental Practice-Based Research Network: Coordinating Center (U01 Clinical Trial Required )
(RFA-DE-19-002)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): July 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Late applications in response to this FOA will not be accepted.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Safe and Effective Devices for Use In Neonatal, Perinatal and Pediatric Care Settings (R43/R44 Clinical Trial Optional)
(RFA-HD-19-001)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): August 1, 2018, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE) (R01 Clinical Trial Not Allowed)
(RFA-HL-19-014)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): June 14, 2018; June 14, 2019; June 15, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.